Steven M. Reister - Concepedia

Author

Steven M. Reister

Also Known As

S. REISTER, S. Reister, Steven M. Reister, Steven Reister

Publications

315

Citations

H-Index

Concepts

All Affiliations

Steven M. Reister is an author at Pfizer (United States) specializing in pharmacotherapy, drug discovery, and drug development.

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	174
2	Medicine	1	1	26
3	Chemical Engineering	1	1	174
4	Chemistry	1	1	174
5	Pharmacology	1	1	26

Steven M. Reister

Publications

315

Citations

H-Index

Page 1

	Year	Citations
Electrophilic Aromatic Bromination Using Bromodimethylsulfonium Bromide Generated in Situ George Majetich, Rodgers Hicks, Steven M. Reister The Journal of Organic Chemistry Chemical EngineeringEngineeringSelective ReagentBromodimethylsulfonium BromideOrganic Chemistry	1997	174
Discovery of Clinical Candidate 4-[2-(5-Amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7 Nigel A. Swain, D. V. Batchelor, Serge Beaudoin, Journal of Medicinal Chemistry	2017	82
2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV Curt D. Haffner, Darryl McDougald, Steven M. Reister, Bioorganic & Medicinal Chemistry Letters Medicinal Chemistry2-Cyano-4-fluoro-1-thiovalylpyrrolidine AnaloguesMedicinePharmacotherapyAnti-cancer Agent	2005	26
Discovery of a Series of Indazole TRPA1 Antagonists David C. Pryde, Brian E. Marron, Christopher W. West, ACS Medicinal Chemistry Letters	2017	23
The discovery of a potent series of carboxamide TRPA1 antagonists David C. Pryde, Brian E. Marron, Caroline West, MedChemComm	2016	10

Page 1